Emerging treatment of acute coronary syndromes with platelet glycoprotein IIB/IIIA inhibitors.
Publication
, Journal Article
Roe, MT; Moliterno, DJ
Published in: J Thromb Thrombolysis
June 1999
Duke Scholars
Published In
J Thromb Thrombolysis
DOI
ISSN
0929-5305
Publication Date
June 1999
Volume
7
Issue
3
Start / End Page
247 / 257
Location
Netherlands
Related Subject Headings
- Treatment Outcome
- Platelet Glycoprotein GPIIb-IIIa Complex
- Platelet Aggregation Inhibitors
- Platelet Aggregation
- Myocardial Infarction
- Injections, Intravenous
- Immunoglobulin Fab Fragments
- Humans
- Electrocardiography
- Drug Costs
Citation
APA
Chicago
ICMJE
MLA
NLM
Roe, M. T., & Moliterno, D. J. (1999). Emerging treatment of acute coronary syndromes with platelet glycoprotein IIB/IIIA inhibitors. J Thromb Thrombolysis, 7(3), 247–257. https://doi.org/10.1023/a:1008927025962
Roe, M. T., and D. J. Moliterno. “Emerging treatment of acute coronary syndromes with platelet glycoprotein IIB/IIIA inhibitors.” J Thromb Thrombolysis 7, no. 3 (June 1999): 247–57. https://doi.org/10.1023/a:1008927025962.
Roe MT, Moliterno DJ. Emerging treatment of acute coronary syndromes with platelet glycoprotein IIB/IIIA inhibitors. J Thromb Thrombolysis. 1999 Jun;7(3):247–57.
Roe, M. T., and D. J. Moliterno. “Emerging treatment of acute coronary syndromes with platelet glycoprotein IIB/IIIA inhibitors.” J Thromb Thrombolysis, vol. 7, no. 3, June 1999, pp. 247–57. Pubmed, doi:10.1023/a:1008927025962.
Roe MT, Moliterno DJ. Emerging treatment of acute coronary syndromes with platelet glycoprotein IIB/IIIA inhibitors. J Thromb Thrombolysis. 1999 Jun;7(3):247–257.
Published In
J Thromb Thrombolysis
DOI
ISSN
0929-5305
Publication Date
June 1999
Volume
7
Issue
3
Start / End Page
247 / 257
Location
Netherlands
Related Subject Headings
- Treatment Outcome
- Platelet Glycoprotein GPIIb-IIIa Complex
- Platelet Aggregation Inhibitors
- Platelet Aggregation
- Myocardial Infarction
- Injections, Intravenous
- Immunoglobulin Fab Fragments
- Humans
- Electrocardiography
- Drug Costs